Figure 3
From: Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors

The evolution of dihydroxypyrimidine-4-carboxamides.
From: Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors
The evolution of dihydroxypyrimidine-4-carboxamides.